RE:How are they doing with FDA approval & financing?There was guidance put out a few months ago the targeted 20 mill Canadian for the PH2 stucy. The compnay just put in about 15-16 mill in the bank. Warrents will most likey fund the remaining balance of the study provided the results are on par with Ph1.
Ph 1 data may also become stronger if an 18 month CR is achived for patient 6 like patient 5.